Pharmacologic Management [hlca]
Atrial Fibrillation [patf]
Current [tmco]
Therapeutic [topp]
strategies [menp]
Atrial Fibrillation [patf]
Form [qlco]
Sustained [ftcn]
Arrhythmia [patf]
frightening [menp]
Complications [patf]
Tachycardia [fndg]
Ventricular Dysfunction [patf]
Often [tmco]
symptoms [ftcn]
pharmacologic therapy [ftcn]
treatment [ftcn]
Maintain [acty]
Sinus rhythm [fndg]
PREVENT [phsu]
recurrences [phpr]
ventricular [bpoc]
Response Rate [tmco]
Methods [inpr]
thi [euka]
Article [inpr]
Published [ocac]
Pharmacological Treatment [topp]
Alternative [cnce]
System [ftcn]
classify [clas]
Atrial Fibrillation [patf]
Choose [acty]
Appropriate [qlco]
pharmacologic therapy [ftcn]
Atrial Fibrillation [patf]
Paroxysmal [tmco]
chronic [tmco]
attacks [socb]
Paroxysmal atrial fibrillation [dsyn]
Duration [tmco]
frequency [qnco]
Functional [ftcn]
Tolerance [fndg]
Classification system [clas]
clinical aspects [clna]
Paroxysmal atrial fibrillation [dsyn]
therapy [ftcn]
Chronic atrial fibrillation [dsyn]
Association [menp]
condition [dsyn]
Atrial [bpoc]
Distension [patf]
Chronic atrial fibrillation [dsyn]
Increased [qnco]
Congestive heart failure [dsyn]
Rheumatic Heart Disease [dsyn]
Mortality rate [qnco]
Patients [podg]
Chronic atrial fibrillation [dsyn]
Disease, Cardiac [dsyn]
Various [irda]
Options [ftcn]
Available [ftcn]
treatment [ftcn]
Chronic atrial fibrillation [dsyn]
Restoration [inpr]
Sinus rhythm [fndg]
ventricular [bpoc]
Cardioversion [topp]
Pharmacologic [bmod]
Electrical [npop]
treatment [ftcn]
Patients [podg]
Cardioversion [topp]
Indicated [fndg]
therapy [ftcn]
Anti-arrhythmic Agent [phsu]
ventricular [bpoc]
Response Rate [tmco]
calcium antagonist [phsu]
Digoxin [carb, phsu, strd]
Beta-Blockers [phsu]
Patients [podg]
Sodium Channel Blockers [phsu]
Potassium Channel Blockers [phsu]
Sotalol [orch, phsu]
Amiodarone [orch, phsu]
PurE [moft]
Class III [inpr]
Agent [chvf]
dofetilide [orch, phsu]
Potassium channel blocker [phsu]
PREVENT [phsu]
recurrent atrial fibrillation [dsyn]
Maintain [acty]
Normal sinus rhythm [fndg]
Conclusions [idcn]
choice [inbe]
Antiarrhythmic drug [phsu]
depend [medd]
absence [qnco]
Structural [spco]
Heart disease [dsyn]
Additional [ftcn]
Concern [idcn]
Chronic atrial fibrillation [dsyn]
Arterial Embolization [dsyn]
Atrial [bpoc]
Stasis [patf]
formation [biof]
Thrombi [patf]
Patients [podg]
Chronic atrial fibrillation [dsyn]
Embolic stroke [dsyn]
Increased [qnco]
Fold [spco]
Anticoagulant therapy [topp]
considered [idcn]
Patients [podg]
High Risk [qlco]
Embolisation [topp]
Appropriate Treatment [clna]
Based [ftcn]
concepts [idcn]
Recently [tmco]
Group [idcn]
Based [ftcn]
Specific [qlco]
Channel [spco]
blocked [patf]
Anti-arrhythmic Agent [phsu]
experience [menp]
Gain [qnco]
Anti-arrhythmic Agent [phsu]
Example [cnce]
Termination [inpr]
Atrial Fibrillation [patf]
Best [qlco]
sodium channel blocker [phsu]
Class I [clas]
Agent [chvf]
Potassium channel blocker [phsu]
Class III [inpr]
Agent [chvf]
Contrast [qlco]
ventricular [bpoc]
Response Rate [tmco]
Controlled [ftcn]
Beta-blocker [phsu]
Propranolol [orch, phsu]
Calcium channel blocker [phsu]
Verapamil [orch, phsu]
Antiarrhythmic drug [phsu]
therapy [ftcn]
Chosen [acty]
Based [ftcn]
Classification [clas]
Cellular [cell]
Electrophysiology [bmod]
effects [qlco]
Drug [phsu]
